Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months.

ABSTRACT: The advancement of nirmatrelvir, the active ingredient in Paxlovid, from discovery to emergency use authorization was achieved in just 17 months, requiring an unprecedented rate of chemical process development.

SUBMITTER: Allais C 

PROVIDER: S-EPMC10069651 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature